Charlotte Viant
- Immunology top 2%
- Immune Cell Function and Interaction 9
- T-cell and B-cell Immunology 8
- IL-33, ST2, and ILC Pathways 5
- Immunotherapy and Immune Responses 3
- Infectious Diseases top 5%
- Viral gastroenteritis research and epidemiology 1
- SARS-CoV-2 and COVID-19 Research 1
-
- Monoclonal and Polyclonal Antibodies Research 2
-
- Eosinophilic Esophagitis 2
- Co-authors
- Éric VivierMichel C. NussenzweigAurore FenisAnna GazumyanThierry WalzerMelissa CipollaThiago Y. OliveiraSophie Degouve
- Partner nations
- United StatesFranceNetherlands
In The Last Decade
Charlotte Viant
10 papers receiving 1.3k citations
Hit Papers
Peers
Comparison fields: 5 of 85
- Immunology 989
- Infectious Diseases 318
- Oncology 180
- Virology 26
- Cancer Research 64
Countries citing papers authored by Charlotte Viant
This map shows the geographic impact of Charlotte Viant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charlotte Viant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charlotte Viant more than expected).
Fields of papers citing papers by Charlotte Viant
This network shows the impact of papers produced by Charlotte Viant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charlotte Viant. The network helps show where Charlotte Viant may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Charlotte Viant, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2022 | 41 | |
| 3 | 2021 | 66 | |
| 4 | 2021 | 7 | |
| 5 | 2020 | 130 | |
| 6 | Enhanced SARS-CoV-2 neutralization by dimeric IgAbreakdown → | 2020 | 294 |
| 7 | 2017 | 4 | |
| 8 | 2017 | 177 | |
| 9 | 2016 | 80 | |
| 10 | 2014 | 96 | |
| 11 | The metabolic checkpoint kinase mTOR is essential for IL-15 signaling during the development and activation of NK cellsbreakdown → | 2014 | 462 |
About Charlotte Viant
Charlotte Viant is a scholar working on Immunology, Biotechnology and Radiology, Nuclear Medicine and Imaging, having authored 11 papers that have together received 1.4k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (9 papers), T-cell and B-cell Immunology (8 papers), IL-33, ST2, and ILC Pathways (5 papers), Immunotherapy and Immune Responses (3 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Eosinophilic Esophagitis (2 papers), Viral gastroenteritis research and epidemiology (1 paper) and SARS-CoV-2 and COVID-19 Research (1 paper). The work is most often cited by research in Immunology (989 citations), Infectious Diseases (318 citations) and Oncology (180 citations). Charlotte Viant has collaborated with scholars based in United States, France and Netherlands. Frequent co-authors include Éric Vivier, Michel C. Nussenzweig, Aurore Fenis, Anna Gazumyan, Thierry Walzer, Melissa Cipolla, Thiago Y. Oliveira, Sophie Degouve, Yann‐Gaël Gangloff and Jacques Bienvenu. Their work appears in journals such as Cell, Science Translational Medicine, Science, Nature Communications and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.